Advancing Chimeric Antigen Receptor T Cell Therapy With CRISPR/Cas9
Protein & Cell - Germany
doi 10.1007/s13238-017-0410-x
Full Text
Open PDFAbstract
Available in full text
Date
April 22, 2017
Authors
Publisher
Springer Science and Business Media LLC